Acquired factor V inhibitors: a systematic review

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Thrombosis and Thrombolysis

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11239-010-0529-6PMID 21052780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A case report of an acquired inhibitor to coagulation factor V

  2011cited by this paper
• Topical recombinant human thrombin in surgical hemostasis.

  2010cited by this paper
• Recombinant Activated Factor VII: Mechanisms of Action and Current Indications

  2010cited by this paper
• Acquired factor V inhibitor

  2010cited by this paper
• Acquired factor V inhibitor in a critically ill patient

  2009cited by this paper
• Acquired factor V inhibitor

  2009influential reference
• A circulating anticoagulant against factor V.

  2009cited by this paper
• A circulating factor V inhibitor: possible side effect of treatment with streptomycin.

  2009cited by this paper
• Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation

  2009cited by this paper
• Laboratory, clinical and therapeutic aspects of acquired hemophilia A.

  2008cited by this paper
• The Diversity in Clinical Presentation of Acquired Factor V Inhibitor

  2008cited by this paper
• Successful treatment with rituximab in a patient with an acquired factor V inhibitor

  2008cited by this paper
• Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.

  2008cited by this paper
• An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1

  2008cited by this paper
• [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].

  2008cited by this paper
• Thrombin generation assay in a patient with acquired factor V inhibitor

  2008cited by this paper
• Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers.

  2007cited by this paper
• Acquired factor V inhibitor after haematopoietic stem cell transplantation

  2007cited by this paper
• Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma

  2007cited by this paper
• Acquired Factor V Inhibitor: A Case Report

  2006cited by this paper
• Spectrum of Bleeding in Acquired Factor V Inhibitor: A Summary of 33 Cases

  2006cited by this paper
• Identification of factor inhibitors by diagnostic haemostasis laboratories

  2006cited by this paper
• Factor V inhibitor: case report.

  2006cited by this paper
• Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays

  2006cited by this paper
• [Acquired factor V inhibitors in a polytraumatized patient].

  2005cited by this paper
• Acquired hemophilia A: A concise review

  2005cited by this paper
• A case of an asymptomatic idiopathic inhibitor to coagulation factor V

  2005influential reference
• Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient

  2005cited by this paper
• Acquired inhibitor of factor V: first report in China and literature review

  2004cited by this paper
• Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation

  2004cited by this paper
• Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis

  2004influential reference
• Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy

  2003cited by this paper
• [A long-lasting idiopathic factor V inhibitor].

  2003cited by this paper
• [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].

  2003cited by this paper
• Anti‐factor V auto‐antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

  2003influential reference
• High‐dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors

  2003cited by this paper
• [Acquired inhibitor against coagulation factor V with severe hematuria].

  2003cited by this paper
• Massive Blutungsneigung bei zwei Patienten mit Faktor-V-Hemmkörper und Anti-Phospholipid-Antikörpern nach Ciprofloxacin-Einnahme

  2003cited by this paper
• Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations.

  2002cited by this paper
• High‐titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors

  2002cited by this paper
• Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure

  2002cited by this paper
• [Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis].

  2002cited by this paper
• Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.

  2002cited by this paper
• Immunologic Impact and Clinical Outcomes After Surgical Exposure to Bovine Thrombin

  2001cited by this paper
• Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig‐Therasorb)

  2001cited by this paper
• Severe Hemorrhagic Complication Due to Acquired Factor V Inhibitor After Single Exposure to Bovine Thrombin Product

  2000cited by this paper
• Inhibitor against coagulation factor V after liver transplantation.

  1999cited by this paper
• Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.

  1999cited by this paper
• Clinical and laboratory manifestations of anti-factor V antibodies.

  1999cited by this paper
• An acquired factor V inhibitor: clinical and laboratory features.

  1999cited by this paper
• Factor V inhibitor in a liver transplant patient associated with porcine xenoperfusion.

  1998cited by this paper
• Factor V inhibitor associated with cold agglutinin disease

  1998cited by this paper
• Acquired factor V inhibitors.

  1998influential reference
• Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features.

  1998cited by this paper
• Acquired factor V inhibitor in a patient with acquired human immunodeficiency syndrome

  1996cited by this paper
• Multimodality therapy of an acquired factor V inhibitor

  1996influential reference
• Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis

  1995influential reference
• Factor V inhibitor associated with Sjögren's syndrome

  1995cited by this paper
• Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid.

  1995cited by this paper
• Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression

  1995cited by this paper
• Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report.

  1995cited by this paper
• Severe bleeding caused by an inhibitor to coagulation factor V: a case report.

  1994cited by this paper
• Factor V inhibitor in thrombosis

  1993cited by this paper
• Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V

  1993cited by this paper
• [Acquired factor V inhibitor treated with intravenous immunoglobulins].

  1992cited by this paper
• Factor V inhibitor developing after liver transplantation in a 3-year-old child.

  1991cited by this paper
• Factor V inhibitor in celiac disease.

  1989cited by this paper
• Bleeding due to an acquired inhibitor of platelet associated factor V.

  1989cited by this paper
• Apparition d'un anticoagulant circulant antifacteur V après intervention chirurgicale

  1989cited by this paper
• [Factor V inhibitor with double cancer].

  1989cited by this paper
• [Occurrence of a circulating anticoagulant, factor V inhibitor after surgical intervention].

  1989cited by this paper
• A spontaneous factor V inhibitor with unexpected laboratory features.

  1986cited by this paper
• Factor V inhibitor associated with immune complex formation.

  1986cited by this paper
• Isolation and study of an acquired inhibitor of human coagulation factor V.

  1986cited by this paper
• Immune complexes containing factor V in a patient with an acquired neutralizing antibody.

  1985cited by this paper
• A case of factor V inhibitor

  1985cited by this paper
• The response of an acquired Factor V inhibitor to activated Factor IX concentrate

  1985cited by this paper
• An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer.

  1981cited by this paper
• [A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)].

  1981cited by this paper
• [A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].

  1980cited by this paper
• Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions.

  1980cited by this paper
• Factor V antibody and disseminated intravascular coagulation.

  1978cited by this paper
• A circulating anticoagulant against factor V.

  1978cited by this paper
• Hemorrhagic death associated with a high titer factor V inhibitor

  1978cited by this paper
• Acquired Inhibitors of Factor V

  1978cited by this paper
• Factor V inhibitor and bullous pemphigoid.

  1977cited by this paper
• Observations on a Factor‐V Inhibitor

  1975cited by this paper
• Massive hemorrhage associated with circulating antibodies to factor V.

  1973cited by this paper
• Factor V inhibitor: report of a case, with comments on a possible effect of streptomycin.

  1973cited by this paper
• Factor V anticoagulants: clinical, biochemical, and immunological observations.

  1970cited by this paper
• A Circulating Anticoagulant Specific for Factor V

  1969cited by this paper
• A specific inhibitor of human clotting factor V.

  1968cited by this paper
• A circulation inhibitor (anti-AcG) specific for the labile factor-V of the blood-clotting mechanism.

  1958cited by this paper

• A Case Report of Non‐Neutralizing Acquired Factor V Inhibitor Mimicking Deficiency: Diagnostic Challenges and Therapeutic Implications

  2026cites this paper
• A Case of an Acquired Factor V Inhibitor Triggered by Levofloxacin and Ceftazidime and Effectively Treated With Clinical Pharmacist Assistance

  2025cites this paper
• Successful Hemostasis With Platelet Transfusion and Tranexamic Acid, and Inhibitor Elimination With Cyclosporine, in Steroid-Resistant Acquired Coagulation Factor V Deficiency Caused by Antibiotic Readministration

  2025influential citation
• Autoimmune Acquired Factor V Deficiency in a Patient With Pancreatic Cancer Complicated by Cholangitis: A Rare Coagulopathy With a Favorable Course

  2025cites this paper
• Inhibitor Development in Severe Congenital Factor V Deficiency.

  2025cites this paper
• A child with factor V deficiency with a novel F5 gene mutation misdiagnosed as a left iliac fossa abscess: A case report

  2024cites this paper
• Postoperative Bleeding due to Acquired Factor V Inhibitor Appearing after Cholecystectomy—A Case Report—

  2024cites this paper
• Severe coagulation disorder occurring after broad-spectrum antibiotic therapy in a patient with longstanding infection

  2024influential citation
• Acquired factor V inhibitor treated with rituximab

  2024cites this paper
• Acquired factor V inhibitor in a case of pediatric venous thrombosis

  2024cites this paper
• Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis

  2023cites this paper
• Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant

  2023cites this paper
• A Case Report of Connective Tissue Disease Combined with Acquired Factor V Deficiency

  2023cites this paper
• Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report

  2023influential citation
• A hemodialysis patient with acquired factor V inhibitor who developed cerebral hemorrhage: A case report

  2023cites this paper
• A Case of Acquired Factor V Inhibitor Following Nivolumab Administration

  2022cites this paper
• Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy

  2022cites this paper
• Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease

  2022influential citation
• Factor V deficiency with a unique genetic mutation presenting as post-circumcision bleeding in a neonate, A-case-report

  2022cites this paper
• Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report

  2022cites this paper
• Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends

  2022cites this paper
• Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)

  2021cites this paper
• Coagulation factor V inhibitors, a review of the case report literature

  2021cites this paper
• Acquired factor V inhibitor presenting as life threatening bleeding after initiation of apixaban

  2021cites this paper
• Intestinal Intramural Hematoma due to Acquired Factor V Inhibitor—A Case Report—

  2021cites this paper
• A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan

  2021influential citation
• Acquired Factor V Inhibitor: success of steroids in a patient with primary sclerosing cholangitis, ulcero haemorrhagic rectocolitis, biological Biermer's disease.

  2021cites this paper
• Autoimmune Factor V Deficiency That Took 16 Years to Diagnose due to Pseudodeficiency of Multiple Coagulation Factors

  2021cites this paper
• Development of Acquired Factor V Inhibitor After Surgical Procedure Without the Use of Fibrin Tissue Adhesives: A Case Report

  2021influential citation
• Acquired factor V inhibitor: a nation‐wide study of 38 patients

  2021cites this paper
• Thermally driven formation of polyphenolic carbonized nanogels with high anticoagulant activity from polysaccharides.

  2021cites this paper
• Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection.

  2021cites this paper
• Multiple thrombosis associated with Cytomegalovirus enterocolitis in an immunocompetent patient: a case report

  2021cites this paper
• Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy

  2021influential citation
• Acquired Factor V Inhibitor Complicated with Immune Thrombocytopenia

  2021influential citation
• Acute spontaneous subdural hematoma as an inaugural presentation of systemic lupus erythematosus with acquired factor XIII deficiency: a case report

  2021cites this paper
• Autoimmune Clotting Dysfunction

  2020cites this paper
• Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review

  2020cites this paper
• Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog

  2020influential citation
• A Case of Acquired Factor V Deficiency in Patient with Bleeding

  2020cites this paper
• Advances in managing rare acquired bleeding disorders

  2020cites this paper
• An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient

  2020cites this paper
• A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents

  2020cites this paper
• Successful Management of Life-threatening Pelvic Hemorrhage From Acquired Factor V Deficiency With immunosuppressive Therapy

  2020influential citation
• Acquired Factor V Inhibitor After Antibiotic Therapy: A Clinical Case Report and Review of the Literature

  2020cites this paper
• Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy

  2019cites this paper
• An unusual cause of bruising

  2019cites this paper
• Importance of platelet activation in the regulation of whole blood coagulation in the presence of a factor V inhibitor

  2019cites this paper
• A Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency

  2019cites this paper
• The potential value of thrombin generation assay in the diagnosis of FV inhibitors

  2019cites this paper
• Dramatic decreases of all haemorrhagic coagulation factors by acquired inhibitors after extended left lobectomy

  2019cites this paper
• A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome

  2019cites this paper
• Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency

  2019cites this paper
• Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases

  2019cites this paper
• Management of rare acquired bleeding disorders.

  2019influential citation
• Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment

  2019cites this paper
• Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.

  2018cites this paper
• Acquired factor V inhibitor-related severe bleeding due to unformed prothrombinase complex.

  2018cites this paper
• Elevated PT and aPTT.

  2018cites this paper
• The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency

  2018cites this paper
• Congenital Factor VII Deficiency

  2018cites this paper
• Two cases of acquired factor V inhibitor which were initially diagnosed with congenital deficiency by cross mixing tests

  2018cites this paper
• Not as sweet as honey: A rare case of an apparent factor V “inhibitor” in association with bee sting anaphylaxis

  2018cites this paper
• A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment

  2018cites this paper
• A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors

  2018cites this paper
• Fatal hemorrhage due to a spontaneous factor V inhibitor with lupus anticoagulant properties.

  2017cites this paper
• High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors

  2017cites this paper
• Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis

  2017cites this paper
• Successful Outcome of Severe Intra-cerebral Bleeding Associated with Acquired Factor V Inhibition: Utilization of Multiple Therapeutic Agents

  2017influential citation
• Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia

  2017cites this paper
• Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database.

  2017influential citation
• Factor V Inhibitors: A Diagnostic and Therapeutic Challenge.

  2017cites this paper
• Acquired Factor V Inhibitor in a Cancer Patient: Failure of Immunosuppressive and Rituximab Treatment

  2017cites this paper
• Hematuria in a Former Smoker.

  2017cites this paper
• Transient FV inhibitor of unknown origin in difficult clinical situation

  2017influential citation
• Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders

  2017cites this paper
• A patient having acquired factor V inhibitor unable to be managed by plasma exchange

  2017cites this paper
• Acquired factor V deficiency following transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report

  2017cites this paper
• A Case of Acquired Factor V Deficiency after Percutaneous Coronary Intervention

  2017influential citation
• Acquired Factor V Inhibitors: A Review of Literature

  2017cites this paper
• Search Methods We reviewed the medical literature for published studies on alloantibodies in patients with inherited bleeding disorders other than hemophilia

  2017cites this paper
• [A Case of Acquired Factor V Deficiency Associated with IgG4-related Disease].

  2016cites this paper
• Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature

  2016cites this paper
• A diagnostic algorithm for the detection of inhibitors against coagulation Factor V

  2016cites this paper
• Acquired Factor V Inhibitor

  2016influential citation
• Acquired Inhibitors of Coagulation

  2016cites this paper
• Transfusion management of factor V deficiency: three case reports and review of the literature

  2016influential citation
• Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease

  2016cites this paper
• Bleeding Associated with Coagulation Factor Inhibitors

  2016cites this paper
• Factor V Deficiency in Korean Patients: Clinical and Laboratory Features, Treatment, and Outcome

  2016influential citation
• Acquired factor V inhibitor in a patient receiving venous-venous extracorporeal membrane oxygenation for Legionella pneumonia.

  2015cites this paper
• Complete response of acquired FV inhibitor to rituximab

  2015cites this paper
• Thrombin generation in a patient with an acquired high-titre factor V inhibitor

  2015cites this paper
• Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor

  2015cites this paper
• Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

  2015cites this paper
• Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure

  2015cites this paper
• Acquired Hemostatic Disorders

  2015cites this paper
• Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors

  2014cites this paper
• Prolongation of Both PT and aPTT

  2014cites this paper
• Successful treatment of severe lung hemorrhage caused by acquired factor V inhibitor with rituximab.

  2014cites this paper